PATENT CLAIM ANALYSIS

Application Number: 15867609
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["424", "172100"]

Abstract:
The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a Sortilin protein, e.g., human Sortilin or a mammalian Sortilin, and use of such compostions in preventing, reducing risk, or treating an individual in need thereof.

Claim (Index 11):
The anti-Sortilin antibody of  claim 1 , wherein the anti-Sortilin antibody has a human Fc IgG1 isotype and comprises an amino acid substitution in the Fc region at residue position L234A and L235A, wherein the numbering of the residues is according to EU numbering.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.43478
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15285359', '15756043', '15743549', '14129053', '14933517']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7897576889657334
- 35 USC 102 Novelty (BERT): 0.664332955418194
- Combined Prediction Score: 0.7772152156109795
- Mean Citation Score: 446.529264
- Max Citation Score: 709.19763
- Similarity Product: 549.5766596875262

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test